Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 3,048 | 3,498 | 2,847 | 2,927 | 3,392 |
| Gross Profit | 3,048 | 3,498 | 2,847 | 2,927 | 3,392 |
| Operating Expenses | 27,902 | 17,465 | 15,839 | 18,495 | 20,441 |
| Operating Income | -24,854 | -13,967 | -12,992 | -15,568 | -17,049 |
| Interest Expense | 0 | 0 | 0 | 24 | 27 |
| Other Income | 77 | 127 | -64 | -83 | -88 |
| Pre-tax Income | -24,777 | -13,840 | -13,056 | -15,675 | -17,164 |
| Net Income Continuous | -24,777 | -13,840 | -13,056 | -15,675 | -17,164 |
| Net Income | $-24,777 | $-13,840 | $-13,056 | $-15,675 | $-17,164 |
| EPS Basic Total Ops | -0.94 | -0.53 | -0.93 | -0.90 | -0.90 |
| EPS Basic Continuous Ops | -0.94 | -0.53 | -0.47 | -0.86 | -0.94 |
| EPS Diluted Total Ops | -0.94 | -0.53 | -0.93 | -0.90 | -0.90 |
| EPS Diluted Continuous Ops | -0.94 | -0.53 | -0.47 | -0.86 | -0.94 |
| EBITDA(a) | $-24,277 | $-13,364 | $-12,420 | $-15,066 | $-16,472 |